Related papers: A Wearable ECG Device for Differentiating Hypertro…
Objective: A novel ECG classification algorithm is proposed for continuous cardiac monitoring on wearable devices with limited processing capacity. Methods: The proposed solution employs a novel architecture consisting of wavelet transform…
Cardiac abnormalities affecting heart rate and rhythm are commonly observed in both healthy and acutely unwell people. Although many of these are benign, they can sometimes indicate a serious health risk. ECG monitors are typically used to…
Cardiovascular disease has become one of the most significant threats endangering human life and health. Recently, Electrocardiogram (ECG) monitoring has been transformed into remote cardiac monitoring by Holter surveillance. However, the…
Hypertrophic cardiomyopathy (HCM) requires accurate risk stratification to inform decisions regarding ICD therapy and follow-up management. Current established models, such as the European Society of Cardiology (ESC) score, exhibit moderate…
Cardiovascular diseases (CVDs) are the number one cause of death worldwide. While there is growing evidence that the atrial fibrillation (AF) has strong associations with various CVDs, this heart arrhythmia is usually diagnosed using…
The electrocardiogram or ECG has been in use for over 100 years and remains the most widely performed diagnostic test to characterize cardiac structure and electrical activity. We hypothesized that parallel advances in computing power,…
Left ventricular hypertrophy (LVH) results from chronic remodeling caused by a broad range of systemic and cardiovascular disease including hypertension, aortic stenosis, hypertrophic cardiomyopathy, and cardiac amyloidosis. Early detection…
Cardiovascular disease remains the leading cause of death globally, underscoring the need for effective, accessible monitoring solutions, particularly through wearable devices that enable continuous, real-time tracking of heart rhythms in…
Hypertrophic cardiomyopathy (HCM) and cardiac amyloidosis (CA) are both heart conditions that can progress to heart failure if untreated. They exhibit similar echocardiographic characteristics, often leading to diagnostic challenges. This…
Heartbeat classification using electrocardiogram (ECG) data is a vital assistive technology for wearable health solutions. We propose heartbeat feature classification based on a novel sparse representation using time-frequency joint…
Sudden cardiac death and arrhythmia account for a large percentage of all deaths worldwide. Electrocardiography (ECG) is the most widely used screening tool for cardiovascular diseases. Traditionally, ECG signals are classified manually,…
Electrocardiogram (ECG) is the most frequent and routine diagnostic tool used for monitoring heart electrical signals and evaluating its functionality. The human heart can suffer from a variety of diseases, including cardiac arrhythmias.…
A combination of cloud-based deep learning (DL) algorithms with portable/wearable (P/W) devices has been developed as a smart heath care system to support automatic cardiac arrhythmias (CAs) classification using electrocardiography (ECG).…
Psychiatric disorders affect millions globally, yet their diagnosis faces significant challenges in clinical practice due to subjective assessments and accessibility concerns, leading to potential delays in treatment. To help address this…
Arrhythmia, an abnormal cardiac rhythm, is one of the most common types of cardiac disease. Automatic detection and classification of arrhythmia can be significant in reducing deaths due to cardiac diseases. This work proposes a multi-class…
Left Ventricular Hypertrophy (LVH) is a major cardiovascular risk factor, linked to heart failure, arrhythmia, and sudden cardiac death, often resulting from chronic stress like hypertension. Electrocardiography (ECG), while varying in…
Cardiovascular diseases remain the leading cause of morbidity and mortality, particularly in aging populations, with rising rates of heart-related incidents in middle-aged and even younger individuals. Currently available electrocardiogram…
Hypertrophic cardiomyopathy (HCM) patients have a high incidence of atrial fibrillation (AF) and increased stroke risk, even with low risk of congestive heart failure, hypertension, age, diabetes, previous stroke/transient ischemic attack…
Clinical risk stratification for sudden cardiac death (SCD) in hypertrophic cardiomyopathy (HC) employs rules derived from American College of Cardiology Foundation/American Heart Association (ACCF/AHA) guidelines or the HCM Risk-SCD model…
Since cadiovascular disease (CVD) posts a heavy threat to people's health, long-term electrocardiogram (ECG) monitoring is of great value for the improvement of treatment. To realize remote long-term ECG monitoring, a low-power wireless…